Pharmaceuticals

Global Cancer Vaccines Market Forecast 2026–2035 Presenting Long-Term Growth Insights

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Cancer Vaccines Market Across 2026–2030?

The cancer vaccines market has experienced rapid expansion in recent years. Its value is expected to rise from $9.36 billion in 2025 to $10.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. This historical growth can be linked to factors such as the increasing worldwide incidence of cancer, the constrained efficacy of standard cancer treatments, heightened understanding of cancer immunotherapy, growing investment in oncology research, and early regulatory clearances for cancer vaccines.

The cancer vaccines market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $18.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. The growth observed during the forecast period can be attributed to several factors, including advancements in vaccine platforms and delivery mechanisms, the rising acceptance of personalized cancer vaccines, the broadening of clinical pipelines for therapeutic vaccines, an increase in government funding dedicated to cancer research, and the escalating demand for combination cancer therapies. Key trends expected within this period encompass the escalating development of therapeutic cancer vaccines, a heightened emphasis on personalized and targeted immunotherapies, an increase in clinical trials for innovative cancer vaccine technologies, the expansion of preventive vaccination initiatives aimed at cancer prevention, and an uptick in collaborations between pharmaceutical companies and research institutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

Which Market Drivers Are Supporting The Expansion Of The Cancer Vaccines Market?

Enhanced government financial support for research and development is projected to propel the expansion of the cancer vaccines market moving forward. Government funding refers to financial resources allocated by a government for a specific purpose. This investment in research and development is increasing to foster innovation and accelerate the creation of new technologies and treatments that can address crucial health and economic challenges. Cancer vaccines support government funding for research and development by creating opportunities for investment in preventive and therapeutic innovations, encouraging increased financial backing for vaccine research programs. For example, in September 2023, the National Cancer Institute, a US-based government agency, received a budget of $7.3 billion from the United States Congress for fiscal year 2023, which marks a $408 million increase over 2022. Thus, the growing government funding for research and development is stimulating the growth of the cancer vaccines market.

What Segmentation Levels Are Considered In The Cancer Vaccines Market?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

What Trends Are Projected To Affect The Cancer Vaccines Market?

Leading firms within the cancer vaccines market are concentrating more on deploying quadrivalent vaccines to boost their earnings within the sector. A quadrivalent vaccine is defined as a vaccine engineered to offer protection against four distinct strains or variants of a particular virus or bacterium. An example includes Serum Institute of India, an India-based biotechnology enterprise, which introduced CERVAVAC, India’s inaugural cervical cancer vaccine, in January 2023. This vaccine targets HPV types 16 and 18, along with 6 and 11, collectively accounting for a minimum of 70% of cervical cancer cases. Administration of the vaccine will involve an injection, given in two doses for individuals aged 9–14 years, and three doses for the age group of 15 to 26.

Which Leading Firms Are Contributing To The Growth Of The Cancer Vaccines Market?

Major companies operating in the cancer vaccines market are GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

Read the full cancer vaccines market report here:

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

How Is The Cancer Vaccines Market Distributed Across Key Geographic Regions?

North America was the largest region in the cancer vaccines market in 2025. The regions covered in the cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cancer Vaccines Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3452&type=smp

Browse Through More Reports Similar to the Global Cancer Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795